PATENT CLAIM ANALYSIS

Application Number: 16277865
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["514", "311000"]

Abstract:
The present invention provides for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, such as MDA and HNE.

Claim (Index 83):
The method of  claim 81 , wherein the sulfobutylether-\u03b2-cyclodextrin is present at about 9.5% w/v.

Metadata:
- Claim Count in Document: 122.0
- Percentile: 99.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15590708', '14760039', '16262364', '15754065', '15924005']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7462402262912793
- 35 USC 102 Novelty (BERT): 0.56726413655098
- Combined Prediction Score: 0.7283426173172494
- Mean Citation Score: 328.04032199999995
- Max Citation Score: 426.14886
- Similarity Product: 335.5708502300835

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test